Literature DB >> 7241298

Duane's retraction syndrome associated with morning glory syndrome.

K Kawano, S Fujita.   

Abstract

A 9-year-old boy with Duane's retraction syndrome and morning glory syndrome is presented. The right eye showed a grayish-pink optic disc, which had a deep excavation containing a white mass in its center and was surrounded by an annulus of pigment disturbance, i.e., consistent with the features of morning glory syndrome. The left eye had a congenital disturbance of ocular motility, which was typical of Duane's retraction syndrome. This is probably the first report of the association of Duane's retraction syndrome and morning glory syndrome. It is hypothesized that a noxious stimulus given at around two months of gestation was responsible for this rare association.

Entities:  

Mesh:

Year:  1981        PMID: 7241298     DOI: 10.3928/0191-3913-19810101-15

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  5 in total

Review 1.  Thalidomide embryopathy: a model for the study of congenital incomitant horizontal strabismus.

Authors:  M T Miller
Journal:  Trans Am Ophthalmol Soc       Date:  1991

Review 2.  The morning glory disc anomaly: contractile movement, classification, and embryogenesis.

Authors:  S Pollock
Journal:  Doc Ophthalmol       Date:  1987-04       Impact factor: 2.379

3.  Poland syndrome associated with 'morning glory' syndrome (coloboma of the optic disc).

Authors:  D T Pisteljić; D Vranjesević; S Apostolski; D D Pisteljić
Journal:  J Med Genet       Date:  1986-08       Impact factor: 6.318

4.  Morning glory syndrome associated with marked persistent hyperplastic primary vitreous and lens colobomas.

Authors:  G Cennamo; G Liguori; A Pezone; G Iaccarino
Journal:  Br J Ophthalmol       Date:  1989-08       Impact factor: 4.638

5.  Morning glory syndrome: clinical and electrofunctional study of three cases.

Authors:  G Giuffrè
Journal:  Br J Ophthalmol       Date:  1986-03       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.